Use of progestogen-only contraceptives/medications and lipid parameters in women age 40 to 42 years: results of a population-based cross-sectional Norwegian Survey-Reference-Cited by-同舟云学术

Use of progestogen-only contraceptives/medications and lipid parameters in women age 40 to 42 years: results of a population-based cross-sectional Norwegian Survey

Published:2002-07 Issue:1 Volume:66 Page:7-13
ISSN:0010-7824
Container-title:Contraception
language:en
Short-container-title:Contraception

Author:

Graff-Iversen Sidsel,Tonstad Serena

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Reproductive Medicine

Reference23 articles.

1. Development of risk factors for cardiovascular disease among women from adolescence to older ages;Kuller;Am J Med Sci,1995

2. Postmenopausal estrogen and progestin use and the risk of cardiovascular disease;Grodstein;N Engl J Med,1996

3. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group;Hulley;JAMA,1998

4. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The postmenopausal estrogen/progestin interventions (PEPI) trial;JAMA,1995

5. Medroxyprogesterone acetate antagonizes the inhibitory effects of conjugated equine estrogen on coronary artery atherosclerosis;Adams;Arterioscler Thromb Vasc Biol,1997

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Special aspects of cholesterol metabolism in women;Deutsches Ärzteblatt international;2024-06-14

2. Moderate Associations Between the Use of Levonorgestrel-releasing Intrauterine Device and Metabolomics Profile;The Journal of Clinical Endocrinology & Metabolism;2024-05-08

3. Sex differences in lipids: A life course approach;Atherosclerosis;2023-11

4. Metabolomics profile of 5649 users and nonusers of hormonal intrauterine devices in Finland;American Journal of Obstetrics and Gynecology;2022-10

Contraceptive Options Following Gestational Diabetes: Current Perspectives

;Open Access Journal of Contraception;2019-10